Changes to our trading names and address – MSD and Organon & Co. read more

Changes to our trading names and address

Please note that in 2021, MSD will be spinning off products from its women’s health, legacy brands, and biosimilars franchises into a new independent, publicly traded company known as Organon & Co.

Due to legal entity separation in advance of this spin off, we now have two UK registered businesses, MSD and Organon. Organon & Co. is a wholly owned subsidiary of Merck & Co., Inc. of Kenilworth, New Jersey, USA.

As a result of the future spin-off of Organon, as well as our head offices moving to London in early 2021, you will begin to see some changes to references to our products, contact details, materials and statements over the coming months.


Top Employer 2021

For the 4th year running - MSD is delighted to have again been recognised for excellence in employee conditions

LEARN MORE

MSD is proud to be investing in the UK.

MSD announces location of new state-of-the-art Discovery Research Centre and UK Headquarters in Central London

LEARN MORE

Addressing antibiotic resistance is more critical than ever. Here’s why.

LEARN MORE

How MSD is responding to the global pandemic, COVID-19

LEARN MORE

Come as you are

LGBTQ+ employees around the world share personal stories about what it means to bring their whole selves to work

LEARN MORE

Learn about how we invent together

Portraits of Invention tells the story of how our people and heritage at MSD enable us to continue ‘Inventing Together’

WATCH OUR CAMPAIGN HERE

GB-NON-03931
Date of Preparation: February 2021